C5 and infection: Here, we overcome these receptor limitations by retargeting HAdV-C5 to T cells using highly specific DARPin adapters, which bridge the virus to different T-cell receptors and also activate the T cells, thereby enhancing transduction and infection efficiency in vitro and in vivo (this study and reference 42).